Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer

© 2017 Elsevier Ltd In the latest trend of anticancer chemotherapy research, there were many macromolecular anticancer drugs developed based on enhanced permeability and retention (EPR) effect, such as albumin bound paclitaxel nanoparticle (nab- PTX, also called Abraxane ® ). However, cancers with l...

Full description

Bibliographic Details
Main Authors: Kinoshita, R., Ishima, Y., Chuang, Victor, Nakamura, H., Fang, J., Watanabe, H., Shimizu, T., Okuhira, K., Ishida, T., Maeda, H., Otagiri, M., Maruyama, T.
Format: Journal Article
Published: Elsevier Ltd 2017
Online Access:http://hdl.handle.net/20.500.11937/54924
_version_ 1848759498630496256
author Kinoshita, R.
Ishima, Y.
Chuang, Victor
Nakamura, H.
Fang, J.
Watanabe, H.
Shimizu, T.
Okuhira, K.
Ishida, T.
Maeda, H.
Otagiri, M.
Maruyama, T.
author_facet Kinoshita, R.
Ishima, Y.
Chuang, Victor
Nakamura, H.
Fang, J.
Watanabe, H.
Shimizu, T.
Okuhira, K.
Ishida, T.
Maeda, H.
Otagiri, M.
Maruyama, T.
author_sort Kinoshita, R.
building Curtin Institutional Repository
collection Online Access
description © 2017 Elsevier Ltd In the latest trend of anticancer chemotherapy research, there were many macromolecular anticancer drugs developed based on enhanced permeability and retention (EPR) effect, such as albumin bound paclitaxel nanoparticle (nab- PTX, also called Abraxane ® ). However, cancers with low vascular permeability posed a challenge for these EPR based therapeutic systems. Augmenting the intrinsic EPR effect with an intrinsic vascular modulator such as nitric oxide (NO) could be a promising strategy. S-nitrosated human serum albumin dimer (SNO-HSA Dimer) shown promising activity previously was evaluated for the synergistic effect when used as a pretreatment agent in nab-PTX therapy against various tumor models. In the high vascular permeability C26 murine colon cancer subcutaneous inoculation model, SNO-HSA Dimer enhanced tumor selectivity of nab-PTX, and attenuated myelosuppression. SNO-HSA Dimer also augmented the tumor growth inhibition of nab-PTX in low vascular permeability B16 murine melanoma subcutaneous inoculation model. Furthermore, nab-PTX therapy combined with SNO-HSA Dimer showed higher antitumor activity and improved survival rate of SUIT2 human pancreatic cancer orthotopic model. In conclusion, SNO-HSA Dimer could enhance the therapeutic effect of nab-PTX even in low vascular permeability or intractable pancreatic cancers. The possible underlying mechanisms of action of SNO-HSA Dimer were discussed.
first_indexed 2025-11-14T10:00:51Z
format Journal Article
id curtin-20.500.11937-54924
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:00:51Z
publishDate 2017
publisher Elsevier Ltd
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-549242017-09-13T15:50:27Z Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer Kinoshita, R. Ishima, Y. Chuang, Victor Nakamura, H. Fang, J. Watanabe, H. Shimizu, T. Okuhira, K. Ishida, T. Maeda, H. Otagiri, M. Maruyama, T. © 2017 Elsevier Ltd In the latest trend of anticancer chemotherapy research, there were many macromolecular anticancer drugs developed based on enhanced permeability and retention (EPR) effect, such as albumin bound paclitaxel nanoparticle (nab- PTX, also called Abraxane ® ). However, cancers with low vascular permeability posed a challenge for these EPR based therapeutic systems. Augmenting the intrinsic EPR effect with an intrinsic vascular modulator such as nitric oxide (NO) could be a promising strategy. S-nitrosated human serum albumin dimer (SNO-HSA Dimer) shown promising activity previously was evaluated for the synergistic effect when used as a pretreatment agent in nab-PTX therapy against various tumor models. In the high vascular permeability C26 murine colon cancer subcutaneous inoculation model, SNO-HSA Dimer enhanced tumor selectivity of nab-PTX, and attenuated myelosuppression. SNO-HSA Dimer also augmented the tumor growth inhibition of nab-PTX in low vascular permeability B16 murine melanoma subcutaneous inoculation model. Furthermore, nab-PTX therapy combined with SNO-HSA Dimer showed higher antitumor activity and improved survival rate of SUIT2 human pancreatic cancer orthotopic model. In conclusion, SNO-HSA Dimer could enhance the therapeutic effect of nab-PTX even in low vascular permeability or intractable pancreatic cancers. The possible underlying mechanisms of action of SNO-HSA Dimer were discussed. 2017 Journal Article http://hdl.handle.net/20.500.11937/54924 10.1016/j.biomaterials.2017.06.021 Elsevier Ltd restricted
spellingShingle Kinoshita, R.
Ishima, Y.
Chuang, Victor
Nakamura, H.
Fang, J.
Watanabe, H.
Shimizu, T.
Okuhira, K.
Ishida, T.
Maeda, H.
Otagiri, M.
Maruyama, T.
Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer
title Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer
title_full Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer
title_fullStr Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer
title_full_unstemmed Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer
title_short Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer
title_sort improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of epr effect and albumin-protein interactions using s-nitrosated human serum albumin dimer
url http://hdl.handle.net/20.500.11937/54924